Supplemental material, sj-tif-2-scm-10.1177_00369330231187655 for The impact of sarcopenia on prognosis of patients with pancreatic cancer: A systematic review and meta-analysis by Hui Gan, Jiarong Lan, Hongxia Bei and Guangxing Xu in Scottish Medical Journal</p
Background: Sarcopenia, which is a subclinical loss of skeletal muscle mass as measured by cross-sec...
Background/objectives Cachexia affects ∼80% of pancreatic cancer patients. An international consensu...
INTRODUCTION: Sarcopenia, a subclinical loss of skeletal muscle mass, is commonly observed in patien...
Supplemental material, sj-tif-4-scm-10.1177_00369330231187655 for The impact of sarcopenia on progno...
Supplemental material, sj-tif-1-scm-10.1177_00369330231187655 for The impact of sarcopenia on progno...
Supplemental material, sj-tif-3-scm-10.1177_00369330231187655 for The impact of sarcopenia on progno...
Supplemental material, sj-docx-5-scm-10.1177_00369330231187655 for The impact of sarcopenia on progn...
Supplemental material, sj-docx-6-scm-10.1177_00369330231187655 for The impact of sarcopenia on progn...
Supplemental material, sj-docx-7-scm-10.1177_00369330231187655 for The impact of sarcopenia on progn...
Supplemental material, sj-docx-8-scm-10.1177_00369330231187655 for The impact of sarcopenia on progn...
Additional file 3: Supplementary Figure 2. Funnel plots for examination of publication bias. (A) ove...
Additional file 2: Supplementary Figure 1. Forest plots of comparison between sarcopenia and non-sar...
BackgroundSarcopenia, characterized by the loss of muscle mass, strength, and physical ability, occu...
Supplemental material, sj-docx-2-tag-10.1177_17562848221142417 for Prognostic impact of sarcopenia i...
Supplemental material, sj-docx-1-sjs-10.1177_14574969221133198 for Markers of sarcopenia increase 30...
Background: Sarcopenia, which is a subclinical loss of skeletal muscle mass as measured by cross-sec...
Background/objectives Cachexia affects ∼80% of pancreatic cancer patients. An international consensu...
INTRODUCTION: Sarcopenia, a subclinical loss of skeletal muscle mass, is commonly observed in patien...
Supplemental material, sj-tif-4-scm-10.1177_00369330231187655 for The impact of sarcopenia on progno...
Supplemental material, sj-tif-1-scm-10.1177_00369330231187655 for The impact of sarcopenia on progno...
Supplemental material, sj-tif-3-scm-10.1177_00369330231187655 for The impact of sarcopenia on progno...
Supplemental material, sj-docx-5-scm-10.1177_00369330231187655 for The impact of sarcopenia on progn...
Supplemental material, sj-docx-6-scm-10.1177_00369330231187655 for The impact of sarcopenia on progn...
Supplemental material, sj-docx-7-scm-10.1177_00369330231187655 for The impact of sarcopenia on progn...
Supplemental material, sj-docx-8-scm-10.1177_00369330231187655 for The impact of sarcopenia on progn...
Additional file 3: Supplementary Figure 2. Funnel plots for examination of publication bias. (A) ove...
Additional file 2: Supplementary Figure 1. Forest plots of comparison between sarcopenia and non-sar...
BackgroundSarcopenia, characterized by the loss of muscle mass, strength, and physical ability, occu...
Supplemental material, sj-docx-2-tag-10.1177_17562848221142417 for Prognostic impact of sarcopenia i...
Supplemental material, sj-docx-1-sjs-10.1177_14574969221133198 for Markers of sarcopenia increase 30...
Background: Sarcopenia, which is a subclinical loss of skeletal muscle mass as measured by cross-sec...
Background/objectives Cachexia affects ∼80% of pancreatic cancer patients. An international consensu...
INTRODUCTION: Sarcopenia, a subclinical loss of skeletal muscle mass, is commonly observed in patien...